Pancreatic Cancer Research

ResearcherTampere UniversityActive in the last 2 years

Johanna Laukkarinen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8239-4861; OpenAlex author ID A5006288518, A5023467909. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 10)
Trials
0
Grants
0
Labs led
1
Collaborators
46
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 3 papers · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 3 papers · 2022: 2 papers · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 15

  1. Upfront surgery vs. neoadjuvant therapy in pancreatic cancer with venous involvement: a multicenter retrospective analysis. Co-author DOI 10.1007/s00423-026-04291-0↗
  2. Surveillance after surgery for pancreatic cancer: a global scoping review of guidelines and a nordic Survey of contemporary practice. Co-author DOI 10.1080/00365521.2024.2378948↗
  3. Margin clearance greater than 1 mm in nodal-positive pancreatic adenocarcinoma patients: multicentre retrospective analysis. Last author DOI 10.1093/bjsopen/zrae076↗
  4. Venous resection for pancreatic cancer, a safe and feasible option? A systematic review and meta-analysis. Co-author DOI 10.1016/j.pan.2022.05.001↗
  5. Bile-volatile organic compounds in the diagnostics of pancreatic cancer and biliary obstruction: A prospective proof-of-concept study. Last author DOI 10.3389/fonc.2022.918539↗
  6. Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer. Co-author DOI 10.1007/s00428-020-02888-4↗
  7. Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer. Co-author DOI 10.1038/s41598-021-91796-x↗
  8. Plasma suPAR may help to distinguish between chronic pancreatitis and pancreatic cancer. Last author DOI 10.1080/00365521.2020.1849383↗
  9. In the Era of the Leeds Protocol: A Systematic Review and A Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma… Last author DOI 10.1177/1457496920911807↗
  10. Access to radical resections of pancreatic cancer is region-dependent despite the public healthcare system in Finland. Last author DOI 10.1136/jech-2017-210187↗
  11. Effect of centralization on long-term survival after resection of pancreatic ductal adenocarcinoma. Last author DOI 10.1002/bjs.10560↗
  12. Quality of life in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy. Last author DOI 10.1016/j.pan.2017.02.013↗
  13. Patients with resected, histologically re-confirmed pancreatic ductal adenocarcinoma (PDAC) can achieve long-term survival despite T3 tumour or nodal involveme… Last author DOI 10.1016/j.pan.2017.07.192↗
  14. Pancreatic cancer. Last author DOI 10.1155/2015/809036↗
  15. Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs. Last author DOI 10.1016/j.ejca.2014.01.011↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Reea Ahola · 7 shared papers, 2017–2026 · strength 0.97
  2. Asif Halimi · 5 shared papers, 2020–2026 · strength 0.88
  3. Benediktas Kurlinkus · 4 shared papers, 2020–2026 · strength 0.72
  4. Eline S. Zwart · 4 shared papers, 2020–2026 · strength 0.72
  5. Guralp Onur Ceyhan · 4 shared papers, 2020–2026 · strength 0.72
  6. Giulio Belfiori · 2 shared papers, 2024–2026 · strength 0.42
  7. Patrick Maisonneuve · 2 shared papers, 2024–2026 · strength 0.42
  8. Keith John Roberts · 2 shared papers, 2024–2026 · strength 0.42
  9. Ernesto Sparrelid · 2 shared papers, 2024–2026 · strength 0.38
  10. Marco Del Chiaro · 2 shared papers, 2015–2026 · strength 0.30
  11. Ilmo Kellokumpu · 2 shared papers, 2021 · strength 0.26
  12. Jan Böhm · 2 shared papers, 2021 · strength 0.26
  13. Kyösti Tahkola · 2 shared papers, 2021 · strength 0.26
  14. Giuseppe Malleo · 1 shared paper, 2026 · strength 0.22
  15. Francesco Giovinazzo · 1 shared paper, 2026 · strength 0.22
  16. Laura Maggino · 1 shared paper, 2026 · strength 0.22
  17. Elena B. Rangelova · 1 shared paper, 2026 · strength 0.22
  18. Gabriella Lionetto · 1 shared paper, 2026 · strength 0.22
  19. Massimo Falconi · 1 shared paper, 2026 · strength 0.22
  20. Geert Kazemier M · 1 shared paper, 2026 · strength 0.22
  21. Stefano Crippa · 1 shared paper, 2026 · strength 0.22
  22. Roberto Salvia · 1 shared paper, 2026 · strength 0.22
  23. Rupaly Pandé · 1 shared paper, 2024 · strength 0.20
  24. Christopher Månsson · 1 shared paper, 2024 · strength 0.16
  25. Bodil Andersson · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.